Alexandros Rampotas

14PUBLICATIONS
73CO-AUTHORS
Molecular targetsTumour immunologyHaematologyMedical biochemistry - proteins and peptides (incl. medical proteomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 01, 2026
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

|Mar 28, 2026
Immunotherapies for Breast Cancer: From Checkpoint Inhibition to Emerging Cellular Therapies.

Ismini Tsagkaraki, Isaac Gannon, Alexandros Rampotas

|Dec 24, 2025
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.

Alexandros Rampotas, Jose Maria Aspa-Cilleruelo, Linda Koster

|Mar 20, 2025
Safety and Efficacy of Busulphan Based on Dosing Patterns in the Real-World Management of Myeloproliferative Neoplasms.

Ali Mahdi, Alexandros Rampotas, Patrick Roberts

|Sep 24, 2024
The present and future of CAR T-cell therapy for adult B-cell ALL.

Alexandros Rampotas, Claire Roddie

|Jan 11, 2022
Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.

Faouzi Djebbari, Alexandros Rampotas, Fotios Panitsas

Pageof 3

Frequent Collaborators

4 joint publications

Claire Roddie

2 joint publications

Faouzi Djebbari

1 joint publications

Anna Alonso-Saladrigues

1 joint publications

Víctor Navarro